Cargando…
The Impact of Clinical Pharmacist Support on Patients Receiving Multi-drug Therapy for Coronary Heart Disease in China
The study determined pharmacist support on patients receiving multi-drug therapy for coronary heart disease by evaluating patient self-care ability, quality of life, and drug therapy compliance. In this study, ninety patients were randomly assigned to an experimental group (n=45) and a control group...
Autores principales: | Zhao, S. J., Zhao, H. W., Du, S., Qin, Y. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502145/ https://www.ncbi.nlm.nih.gov/pubmed/26180276 |
Ejemplares similares
-
Metabolic Syndrome in Adults Receiving Clozapine; The Need for Pharmacist Support
por: Hurley, Kathleen, et al.
Publicado: (2023) -
The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China
por: Moran, Andrew, et al.
Publicado: (2008) -
Impact of pharmacist’s interventions on cost of drug therapy in intensive care unit
por: Saokaew, Surasak, et al.
Publicado: (2009) -
China’s regional inequity in pharmacist’s drug safety practice
por: Tang, Liyang
Publicado: (2012) -
Clinical impact of pharmacist interventions on improving outcomes in patients receiving immune globulin therapy in a home setting
por: DiStefano, Joseph, et al.
Publicado: (2019)